In comparison to the RECIST 1.1 criteria, use of the mpMRI-based NacBI-RADS system for evaluating response to neoadjuvant chemotherapy (NAC) for breast cancer offered an 8 percent higher sensitivity and over 26 percent higher specificity.
|Poll|February 20, 2015
Image IQ: 67-year-old Male, Worsening Fatigue, Jaundice
Author(s)Duke Duncan, MD
67-year-old male with history of worsening fatigue and jaundice.
Advertisement
67-year-old male with history of worsening fatigue and jaundice.
Click on the images to enlarge.
What's your diagnosis?
Advertisement
Related to this article
Catch up on the most-well viewed radiology content in October 2026.
In a new podcast episode, Manisha Bahl, MD, MPH, FSBI, discusses recently published guidelines on proliferative breast lesions with atypia and lobular carcinoma in situ (LCIS).
Catch up on the most well-viewed radiology video interviews from Diagnostic Imaging in September 2026.
Catch up on the top AI-related news and research in radiology over the past month.
Catch up on a variety of FDA news in radiology from the past week.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears CTA-Based AI Software for Brain Aneurysm Detection and Follow-Up
2
Will PCCT Lead the Next Revolution in Interventional Cardiology?
3
FDA Issues Breakthrough Therapy Designation for Emerging PSMA PET Agent in Men with Suspected PCa Recurrence
4
Agfa Radiology to Introduce AI-Powered DR 100s Pro X-Ray Platform at RSNA
5